1Richardson P, Mckenaw W, Bristow M, et al. Report of the 1995 WHO/ISFC Force on the definition of cardiomyopathy[J].Circulation, 1996,93 : 841-842.
2Ronglih Liao, Luigino Nascimben, Jan Friedrich, et al. Decreased energy reserve in an animal model of dilated cardiomyoparhy[J]. Circulation Research, 1996,78:893-902.
3Sodian R, Hoerstrup SP, Sperling JS, et al. Early in vivo experience with tissue-engineered trileaflet heart valves[J]. Circulation, 2000,102 : sⅡ 22-29.
4Weber KT, Brilla CG, Janicki JS. Structural remodeling of myocardial collagen in systemic hypertension: functional conquences and potential therapy[J]. Heart Failure, 1990.6:129-137.
5Sisakian S, Avakian SA, Kamalov GG, et al. The role of quanutative determination of the volume fraction of interstitial collgen and fibronectin in the pathogenesis of myocardiaol remodeling in dilated cardiomyopathy[J]. Klin Med[Mosk]. 2001,79 : 24-26.
6Marijianowski MMH,Teeling P, Mann J, et al. Dilated cardiomyopathyis associated with an increase in the type Ⅰ type Ⅲ collagen ratio:a quantitative assessment[J]. J Am Coll Cardiol,1995,25:1263.
7Lamas GA, Vaughan DE, Parisi AF, et al. Effects of ventricular shape and captopril therapy on exercise capacity after anterior wall acute myocardial infarction[J]. Am J Cardiol, 1989, 63:1167-1173.
8Czarnecki CM, Jankus EF, Huhgren BD. Effect of furazolidone on the development of cardiomyopathies in Turkey poultry[J].Avian Dis,1974,18 : 125-133.
